Disinfection Validation — ISO 15883 / EN 14885

What Is Disinfection Validation?

Disinfection validation proves that the manufacturer's recommended disinfection method reduces the microorganism load on the device to the targeted level. It differs from sterilisation: disinfection removes not all microorganisms but a targeted group, by a defined logarithmic reduction.

Purpose of Disinfection Validation

The purpose is to demonstrate the effectiveness of the disinfection instructions with microbiological data, and to ensure the device's safety for reuse.

Which Products Is Disinfection Validation Applied To?

Endoscopes and semi-critical devices
Breathing circuits and anaesthesia equipment
Reusable probes and sensors
Patient-contact surfaces and accessories

In Which Sectors Is Disinfection Validation Used?

Medical DeviceHealthcarePharmaceuticals

Standards Related to Disinfection Validation

ISO 15883-1
ISO 15883-4
EN 14885
EN 13727
EN 14476
EN 13624
ISO 17664-1
ISO 11607end product sterile barrier packaging test

Disinfection Validation Conditions

Disinfection level: Low, intermediate, or high level; determined according to the device's Spaulding classification
Test microorganisms: Bacterial, yeast, fungal, mycobacterial and viral strains defined in the relevant EN standards
Efficacy criterion: Targeted logarithmic reduction; according to the standard and the claimed spectrum of activity
Soil load: Clean and dirty conditions (interfering substance) are tested separately

Equipment for Disinfection Validation

Microbiology laboratory infrastructure
Washer-disinfector
Incubators and biosafety cabinet
Neutralisation and recovery rigs
Colony counting system

Sample Requirements for Disinfection Validation

The real device or a test surface defined in the standard
Worst-case configuration
The recommended disinfectant, concentration and contact time must be stated
The number of specimens and repetitions must be planned

Duration of Disinfection Validation

Typically several weeks, including the microbiological study and repetitions.

Disinfection Validation Procedure

1The device's Spaulding classification and the required disinfection level are determined.
2Test microorganisms and soil conditions are selected.
3The neutralisation method is validated.
4The device or test surface is contaminated with the defined microorganism load.
5The recommended disinfection cycle is applied.
6Remaining viable microorganisms are recovered and counted.
7The logarithmic reduction is calculated.
8The cycle is repeated to demonstrate consistency.

Disinfection Validation Acceptance Criteria

The acceptance criterion is the minimum logarithmic reduction defined in the relevant EN standard for the claimed spectrum of activity (e.g. the reduction requirement under EN 13727 for bactericidal activity). Which standard applies is determined by the claimed spectrum of activity.

Evaluation of Results

If neutralisation has not been validated, the result cannot be interpreted: residual disinfectant suppresses growth in the culture medium, giving false-positive efficacy. The result under dirty conditions represents real use better than the clean condition.

Disinfection Validation Report

Device description and Spaulding classification
Claimed spectrum of activity and applied standards
Test microorganisms and contamination conditions
Disinfection parameters (disinfectant, concentration, duration, temperature)
Neutralisation validation result
Logarithmic reduction values
Comparison with acceptance criteria

Accreditation

EUROLAB holds internationally recognised accreditation obtained from accreditation bodies party to the IAF and ILAC multilateral recognition arrangements, under ISO/IEC 17025 for laboratory testing, ISO/IEC 17020 for inspection and surveillance, and ISO/IEC 17021-1 and ISO/IEC 17065 for system and product certification. This chain ensures the reports and certificates issued are accepted worldwide.

Whether this test can be offered within accredited scope depends on your product and the standard applied; since accreditation is method-based, the scope is confirmed in writing at the quotation stage.

Scope and authorisations

Related Regulations

MDR (EU) 2017/745
Relationship with the Biocidal Products Regulation
ISO 17664

Medikal Cihaz Testleri — What Does This Testing Field Cover?

The section below describes the field that the Disinfection Validation test belongs to; the conditions and acceptance criteria of this particular test are given in the sections above. The scope specific to your product is confirmed in writing at the quotation stage.

Medical device testing shows that a device is safe for the patient and the user and maintains its intended performance. In this family safety is not only about avoiding harm; a device failing to perform its expected function is also treated as a risk. A monitor missing an alarm or a pump delivering the wrong dose is directly a patient safety event.

At the centre of the field is RISK MANAGEMENT, and this is what sets medical apart from other sectors. The risk management process run under ISO 14971 also determines which tests are required. The test list is not copied from a table of standards; it is derived and justified from the device's intended use, the nature and duration of patient contact, the use environment and foreseeable misuse.

Assessment consists of several separate bodies of work, each with its own set of standards. Biocompatibility runs through the ISO 10993 series, electrical device safety through the IEC 60601 series, sterilisation through ISO 11135/11137/17665, packaging through ISO 11607, software through IEC 62304 and usability through IEC 62366. The quality system (ISO 13485) is the framework that binds these together.

Which tests are required is determined by the device's CLASS and its MODE OF CONTACT WITH THE BODY. A product in brief contact with skin and an implant entering the bloodstream do not go through the same test set; the scope is set by a biological evaluation plan prepared under ISO 10993-1. That plan justifies in writing which endpoints are required and why the others are not.

Packaging and sterilisation are taken as seriously as the device itself in this field. For a sterile device the packaging is not a transport container but the barrier that maintains sterility; if the barrier is breached, the device is no longer sterile. Packaging processes are therefore validated and shelf life is supported by real-time ageing data.

For devices containing software, assessment shifts from testing towards PROCESS assurance. IEC 62304 defines which development and verification steps must be followed according to the safety class of the software; the evidence is the traceability of the development process. Testing software does not make it safe — the process record does.

The clinical side is a separate column of the technical file. Test reports show that the device is technically safe; clinical evaluation establishes that the device delivers the intended clinical benefit and that the benefit-risk balance is acceptable. Neither replaces the other.

Method groups in this field

Biocompatibility
Cytotoxicity, irritation, skin sensitisation, systemic toxicity, haemocompatibility, genotoxicity and local effects after implantation. The required endpoints are set by the ISO 10993-1 plan.
Electrical device safety
IEC 60601-1 basic safety and essential performance; EMC, alarm, usability and environmental requirements through the collateral standards.
Sterilisation validation
Validation of sterilisation processes by ethylene oxide, radiation or moist heat; bioburden and sterility assurance level studies.
Packaging
Integrity of the sterile barrier system, seal strength, distribution simulation and shelf-life studies.
Microbiological tests
Bioburden determination, sterility testing, bacterial endotoxin and, where required, carrier validation studies.
Software and usability
IEC 62304 life cycle evidence and use-error focused evaluation under IEC 62366.

Commonly confused in this field

Cytotoxicity alone is not evidence of biocompatibility; the required set of endpoints is determined and justified according to ISO 10993-1.
An ISO 13485 certificate does not confer CE marking; classification under the MDR, the technical file and the notified body process run separately.
Accelerated ageing does not replace real-time ageing; a shelf life claim is supported by real-time data.
A change of material (supplier, pigment, sterilisation method) may require the biological evaluation to be repeated; it is not a silent change.
An assessment made without the collateral and particular standards for IEC 60601-1 is incomplete; which -1-x and -2-x standards were applied must appear in the report.
In vitro diagnostic devices fall under the IVDR rather than the MDR, and laboratory equipment is often on the IEC 61010-1 side.

Which decisions these results support

MDR/IVDR technical file and notified body assessment
Completing the biological evaluation plan
Sterilisation and packaging validation
Determining shelf life and storage conditions
Determining the scope of reassessment after a design change

Related Tests

Frequently Asked Questions About Disinfection Validation

Is high-level disinfection considered sterilisation?

No. High-level disinfection removes all microorganisms except bacterial spores; sterilisation targets all viable forms, including spores, and is expressed by the sterility assurance level (SAL). Sterilisation is required for critical devices.

Why must neutralisation be validated?

Disinfectant remaining in the specimen inhibits growth in the culture medium after recovery, giving a low count even if the microorganisms were not killed. It must be shown that neutralisation is both effective and not itself toxic.